Kuendeswa Kutsva Kwezvinodhaka Kurapa Kwekushaya Iron

A BATA FreeRelease 6 | eTurboNews | eTN
Avatar of Linda Hohnholz
rakanyorwa Linda Hohnholz

KYE Pharmaceuticals Inc. nhasi yazivisa kuti yaendesa New Drug Submission (NDS) kuHealth Canada kuti iongororwe uye kubvumidzwa kweAccrufer® (ferric maltol).            

Kana ikatenderwa, Accrufer® ingangove yekutanga kunyorerwa chete nesimbi yekurapa kurapwa yakabvumidzwa neHealth Canada uye kubvumidzwa kwekushambadzira kweAccrufer® kunotarisirwa kunge kuri mukati mehafu yekutanga ya2023.

Doug Reynolds, Mutungamiriri weKYE, akati: "Zvikwata zveShield neKYE zvakashanda nesimba kuunganidza Canada NDS mukati memwedzi yakati wandei uye ndinofara zvikuru kuti ndawana chiitiko ichi."

José A. Menoyo, MD, Chief Medical Officer weShield, akawedzera kuti: “Tiri kufara nekufambira mberi kuri kuitwa mukubatana neKYE kubva pakasainwa chibvumirano cherezinesi muna Ndira. Masangano ese ari maviri akaratidza kubatana kwakanakisa uye anofambiswa kuita kuti Accrufer® iwanikwe kune varwere muCanada vane kushaya simbi nekukurumidza sezvinobvira. Shield Therapeutics yakazvipira kuunza Accrufer®/Feraccru® kuvarwere vane iron inoshomeka pasi rose, uye Canada chinhu chakakosha pachinangwa ichocho.

Nezvomunyori

Avatar of Linda Hohnholz

Linda Hohnholz

Editor mukuru we eTurboNews yakavakirwa muTN HQ.

Subscribe
Notify of
muenzi
0 Comments
Inline feedbacks
Ona zvese zvataurwa
0
Ndingade pfungwa dzako, ndapota taura.x
Govera ku...